IROBOT CORP (IRBT)

US4627261005 - Common Stock

7.24  -0.01 (-0.14%)

After market: 7.249 +0.01 (+0.12%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to IRBT. IRBT was compared to 68 industry peers in the Household Durables industry. Both the profitability and financial health of IRBT have multiple concerns. IRBT has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

IRBT had negative earnings in the past year.
IRBT had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: IRBT reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: IRBT reported negative operating cash flow in multiple years.

1.2 Ratios

IRBT has a Return On Assets of -41.53%. This is amonst the worse of the industry: IRBT underperforms 94.03% of its industry peers.
IRBT has a worse Return On Equity (-155.07%) than 92.54% of its industry peers.
Industry RankSector Rank
ROA -41.53%
ROE -155.07%
ROIC N/A
ROA(3y)-24.41%
ROA(5y)-10.32%
ROE(3y)-70.34%
ROE(5y)-35.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

IRBT's Gross Margin of 22.03% is on the low side compared to the rest of the industry. IRBT is outperformed by 73.13% of its industry peers.
IRBT's Gross Margin has declined in the last couple of years.
IRBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.24%
GM growth 5Y-15.4%

1

2. Health

2.1 Basic Checks

IRBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IRBT has more shares outstanding
Compared to 5 years ago, IRBT has more shares outstanding
IRBT has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.35, we must say that IRBT is in the distress zone and has some risk of bankruptcy.
IRBT has a Altman-Z score of 0.35. This is amonst the worse of the industry: IRBT underperforms 85.07% of its industry peers.
IRBT has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.03, IRBT is not doing good in the industry: 77.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Altman-Z 0.35
ROIC/WACCN/A
WACC10.44%

2.3 Liquidity

IRBT has a Current Ratio of 1.62. This is a normal value and indicates that IRBT is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of IRBT (1.62) is worse than 77.61% of its industry peers.
IRBT has a Quick Ratio of 1.09. This is a normal value and indicates that IRBT is financially healthy and should not expect problems in meeting its short term obligations.
IRBT has a Quick ratio of 1.09. This is comparable to the rest of the industry: IRBT outperforms 53.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.09

2

3. Growth

3.1 Past

The earnings per share for IRBT have decreased strongly by -79.35% in the last year.
The Revenue for IRBT has decreased by -24.74% in the past year. This is quite bad
The Revenue has been decreasing by -4.01% on average over the past years.
EPS 1Y (TTM)-79.35%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-19.74%
Revenue 1Y (TTM)-24.74%
Revenue growth 3Y-14.61%
Revenue growth 5Y-4.01%
Revenue growth Q2Q-14.07%

3.2 Future

IRBT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.18% yearly.
IRBT is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.97% yearly.
EPS Next Y51.94%
EPS Next 2Y34.61%
EPS Next 3Y20.18%
EPS Next 5YN/A
Revenue Next Year-6.87%
Revenue Next 2Y-2.75%
Revenue Next 3Y-0.97%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

IRBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IRBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

IRBT's earnings are expected to grow with 20.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.61%
EPS Next 3Y20.18%

0

5. Dividend

5.1 Amount

No dividends for IRBT!.
Industry RankSector Rank
Dividend Yield N/A

IROBOT CORP

NASDAQ:IRBT (4/19/2024, 7:00:02 PM)

After market: 7.249 +0.01 (+0.12%)

7.24

-0.01 (-0.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap208.22M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.53%
ROE -155.07%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 22.03%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.62
Quick Ratio 1.09
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-79.35%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y51.94%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-24.74%
Revenue growth 3Y-14.61%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y